Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Iopromide

Summary

Persistence. Iopromide is potentially persistent.

Bioaccumulation. Iopromide has low potential for bioaccumulation.

Toxicity. Iopromide has low chronic toxicity.

Risk. The use of iopromide (sales data Sweden 2021) has been considered to result in insignificant environmental risk.

 

This summary information comes from fass.se.

Detailed information

Fass environmental information

Fass environmental information for Ultravist (iopromide) from Bayer (retrieved on 2025-08-27).

Hazard

Persistence: Iopromide showed no biodegradation in the OECD 301E ready biodegradability test and only 23 % in the OECD 302B inherent biodegradability test, both below relevant thresholds. Simulation studies in sewage treatment systems demonstrated > 80 % elimination at high concentrations, but minimal degradation at environmentally relevant levels. Iopromide was also stable under hydrolysis conditions. Based on these results, iopromide is considered potentially persistent.

Bioaccumulation: The log Dow was reported as ‑2.33.

Toxicity: There are data for 3 trophic levels, most sensitive crustacean NOEC ≥ 10000000 microg/L. Comment: Values reported as greater than are not according to the guidelines. The actual value may be lower.

Risk

PEC/PNEC is based on sales data in Sweden in year 2021.

PEC = 0.00508 microg/L.

PNEC = Lowest LC/EC50, ≥ 10000000 microg/L/1000 (Assessment Factor (AF) for 3 acute studies) = 10000 microg/L. Comment in Fass: The PNEC was calculated based on the acute aquatic toxicity data since there was insufficient chronic aquatic toxicity data.

A NOEC value (OECD 211) has been reported, although ≥ 10,000 mg/L for crustaceans. An assessment factor (AF) of 100 could be applied according to the guidelines, but it would not affect the outcome for the risk classification.

PEC/PNEC = 5.08x10-7 which gives the risk insignificant.

Author: Health and Medical Care Administration, Region Stockholm